cannabinoid oromucosal spray Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience

BMC Neurol. 2021 Jun 22;21(1):227. doi: 10.1186/s12883-021-02246-0. Marie D'hooghe 1 2, Barbara Willekens 3 4, Valerie Delvaux 5, Miguel D'haeseleer 6, Daniel Guillaume 7, Guy Laureys 8, Guy Nagels 6, Patrick…

Freedom WaresJune 22, 2021

Canna~Fangled Abstracts

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

Preclinical data suggest some cannabinoids may exert antitumour effects against glioblastoma (GBM). Br J Cancer.…

Freedom WaresFebruary 24, 2021

Canna~Fangled Abstracts

Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis.

Clin Drug Investig. 2020 Mar 4. doi: 10.1007/s40261-020-00895-6. Mantovani LG1,2, Cozzolino P2, Cortesi PA3,4, Patti…

Freedom WaresMarch 4, 2020

Canna~Fangled Abstracts For Your Consideration...

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.

2016 May 9. pii: jnnp-2015-312591. doi: 10.1136/jnnp-2015-312591. Patti F1, Messina S1, Solaro C2, Amato MP3, Bergamaschi R4, Bonavita S5, Bruno Bossio…

Freedom WaresMay 9, 2016

Canna~Fangled Abstracts

A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany

Symposium Paper A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and…

Freedom WaresAugust 24, 2013

cannabinoid oromucosal spray

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis.

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.

A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany

Recent Posts

Archives

Categories